[HTML][HTML] Incidence and fate of refractory type II endoleak after EVAR: a retrospective experience of two high-volume Italian centers

P Sirignano, N Mangialardi, M Nespola, F Aloisi… - Journal of Personalized …, 2022 - mdpi.com
Introduction: The aim of the present study is to report the outcome of patients presenting an
isolated type II endoleak (TIIEL) requiring reintervention and to identify clinical and …

Incidence and Fate of Refractory Type II Endoleak after EVAR: A Retrospective Experience of Two High-Volume Italian Centers

P Sirignano, N Mangialardi, M Nespola… - Journal of …, 2022 - search.proquest.com
Introduction: The aim of the present study is to report the outcome of patients presenting an
isolated type II endoleak (TIIEL) requiring reintervention and to identify clinical and …

Incidence and Fate of Refractory Type II Endoleak after EVAR: A Retrospective Experience of Two High-Volume Italian Centers.

P Sirignano, N Mangialardi, M Nespola… - Journal of …, 2022 - europepmc.org
Introduction: The aim of the present study is to report the outcome of patients presenting an
isolated type II endoleak (TIIEL) requiring reintervention and to identify clinical and …

Incidence and Fate of Refractory Type II Endoleak after EVAR: A Retrospective Experience of Two High-Volume Italian Centers

P Sirignano, N Mangialardi… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction: The aim of the present study is to report the outcome of patients presenting an
isolated type II endoleak (TIIEL) requiring reintervention and to identify clinical and …

Incidence and Fate of Refractory Type II Endoleak after EVAR: A Retrospective Experience of Two High-Volume Italian Centers

P Sirignano, N Mangialardi, M Nespola… - Journal of Personalized …, 2022 - cir.nii.ac.jp
抄録< jats: p> Introduction: The aim of the present study is to report the outcome of patients
presenting an isolated type II endoleak (TIIEL) requiring reintervention and to identify clinical …

[HTML][HTML] Incidence and Fate of Refractory Type II Endoleak after EVAR: A Retrospective Experience of Two High-Volume Italian Centers

P Sirignano, N Mangialardi, M Nespola… - Journal of …, 2022 - ncbi.nlm.nih.gov
Introduction: The aim of the present study is to report the outcome of patients presenting an
isolated type II endoleak (TIIEL) requiring reintervention and to identify clinical and …

Incidence and Fate of Refractory Type II Endoleak after EVAR. A Retrospective Experience of Two High-Volume Italian Centers

P Sirignano, N Mangialardi, M Nespola… - JOURNAL OF …, 2022 - iris.uniroma1.it
Introduction: The aim of the present study is to report the outcome of patients presenting an
isolated type II endoleak (TIIEL) requiring reintervention and to identify clinical and …

Incidence and Fate of Refractory Type II Endoleak after EVAR: A Retrospective Experience of Two High-Volume Italian Centers.

P Sirignano, N Mangialardi… - Journal of …, 2022 - search.ebscohost.com
Introduction: The aim of the present study is to report the outcome of patients presenting an
isolated type II endoleak (TIIEL) requiring reintervention and to identify clinical and …

[PDF][PDF] Incidence and Fate of Refractory Type II Endoleak after EVAR: A Retrospective Experience of Two High-Volume Italian Centers

P Sirignano, N Mangialardi, M Nespola, F Aloisi… - J. Pers. Med, 2022 - iris.uniroma1.it
Introduction: The aim of the present study is to report the outcome of patients presenting an
isolated type II endoleak (TIIEL) requiring reintervention and to identify clinical and …

Incidence and Fate of Refractory Type II Endoleak after EVAR: A Retrospective Experience of Two High-Volume Italian Centers.

P Sirignano, N Mangialardi, M Nespola… - Journal of …, 2022 - europepmc.org
Introduction: The aim of the present study is to report the outcome of patients presenting an
isolated type II endoleak (TIIEL) requiring reintervention and to identify clinical and …